Lexeo Therapeutics, Inc. Common Stock
HealthcareNASDAQ:LXEO · NASDAQ Global Market
+$0.17 today
Vol 0.62M · Avg 0.85M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+10.91%
Period High
$10.63
Period Low
$3.67
Latest
$4.37
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.18B
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
$444.15M
DBV Technologies S.A.
NASDAQ:DBVT
$416.60M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$353.00M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$352.74M
Silence Therapeutics plc
NASDAQ:SLN
$316.00M
Amarin Corporation plc
NASDAQ:AMRN
$315.21M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$296.96M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$211.47M
Mereo BioPharma Group plc
MREO
$48.68M
What is the latest LXEO filing?
The latest filing shown is 4 dated May 20, 2026.
How many recent filings does LXEO have?
Intrinsic Alpha currently shows 20 recent filings for LXEO.
Explore More
Continue the stock analysis
Jump to another research area for this company.